Astellas Pharma US, Inc., a U.S. affiliate of Tokyo-based Astellas Pharma Inc., is a pharmaceutical company dedicated to changing tomorrow by improving the health of people around the world through innovative and reliable pharmaceutical products. In 2005, Astellas was formed by blending the talents, resources and passions of two highly successful firms - Yamanouchi and Fujisawa. In the US, Astellas has an intense focus on five key therapeutic areas - Immunology, Urology, Cardiology, Dermatology and Infectious Disease - and are considered leaders in these fields. At all levels thoughout the company our people are committed to the opportunity to positively affect and improve patient lives while remaining socially responsible to our community and those with whom we work and collaborate.
Businesses at The Illinois Science + Technology Park
Astellas Research Institute of America provides laboratory support for several Astellas products in development.
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.
The Charles River location in Skokie specializes in genetic and in vitrotoxicology assessments and immunoassay services, including quantitative PK/TK assays, immunogenicity testing such as neutralizing antibody assays (cell based, binding or enzymatic), and biomarkers. To learn more about the Charles River unique portfolio and breadth of services, click here.
Cures Within Reach is a medical research non-profit organization, helping patients since 2005 by repurposing drugs and devices to quickly deliver safe and affordable treatments and cures for both common and rare disorders without currently effective treatments.
While patients with catastrophic diseases are suffering, we know that there are immediately usable medical solutions going untested and unused: safe, FDA-approved drugs and devices with potential new uses to improve length and quality of life. By finding and funding clinical trials to test these repurposed treatments, Cures is creating a unique Repurposing Revolution: an innovation pathway to solve unmet medical needs. Our Repurposing Revolution partners are major research institutions that supply us with research ideas, and individuals, organizations, corporations and foundations that want to fund research with tangible outcomes and direct impact.
Exicure, formerly AuraSense Therapeutics, is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatory disorders to oncology.
SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Fresenius Kabi Company is a fully-integrated pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products. Our primary focus is the anesthetic/analgesic, anti-infective, critical care & oncology markets.
Our products are used in hospitals, long-term care facilities, alternate care sites and clinics throughout North America, and are manufactured in a comprehensive range of dosage formulations. Fresenius Kabi makes healthcare more affordable for millions of patients with critical and chronic illness in North America.
iNfinitesimal is a nanotechnology company that develops tools for targeted and controlled cellular delivery of biomolecules, drugs, nanoparticles, or other chemicals in liquid solution. Our mission is to develop emergent nano- and bio-technologies from the laboratory into commercial tools that provide unique capabilities to researchers and enable novel studies that are not possible with conventional tools.
LanzaTech is revolutionizing the way the world thinks about waste carbon by treating it as an opportunity instead of a liability. LanzaTech’s novel gas-to-liquid technology has opened up vast new sources for making low-carbon chemicals and fuels that displace petroleum without the environmental concerns associated with crop- and land-based bioproducts. This flexible technology has the potential to disrupt the current highly centralized petroleum-based energy system by enabling regional production of low-cost, energy from local wastes and residues.
LanzaTech’s biological process provides a common platform to convert a wide variety of gases, into fuels such as ethanol or jet fuel and commodity chemicals such as butadiene used in nylon production or propylene used in plastics manufacture. The process is feedstock flexible and can use gases as varied as industrial flue gas, gasified biomass wastes and residues, or even biogas and high CO2 stranded gas. The technology offers an economic advantage over existing thermo-catalytic technologies at the small scale (<2000 bbl/day), enabling the monetization of local gas sources with minimal capital investment, giving off-grid communities access to clean, cost competitive and reliable energy.
LanzaTech is unique in its focus on re-using the carbon from waste streams, in the breadth of resources it can utilize and the array of low-carbon products that it can make and it is this gas-to-liquid platform that will disrupt the energy landscape as we know it today.
Midwest NeuroResearch Institute (MNRI) is a provider of preclinical and clinical research services. Our research extends to behavioral, cognitive, sentient, and motor-related effects of drugs of abuse - especially the opioids, GHB, cannabinoids and barbiturates, relative to their impact on specific brain sites and receptors. Of special interest are sites and mechanisms of the ascending DA pathways impacted by these drugs. MNRI research also extends to clinical cases involving neuro-trauma; especially brain injuries that involve these and other neurotoxic agents, including their cause and full extent. As a research provider exclusively, MNRI does not offer medical advice or treatment of any kind to patients.
NanoAl LLC produces novel, castable aluminum superalloys, which exhibit, after heat-treatment, high-strength, coarsening-resistant nano-precipitates with tailored compositions and size distributions. One series of alloys is heat-resistant to 400 ºC, with applications for brake rotors and engine parts. Another series of alloys has a combination of high strength and high conductivity, both electrical and thermal, making them attractive for electrical wires and cables. These alloys can significantly lightweight automobiles by replacing heavier alloys, such as cast-iron (brakes), steel (engines) and copper (wires).
A comprehensive healthcare provider offering a full range of medical services. They operate four hospitals in the greater North Shore area including Evanston, Glenbrook, Highland Park, and Skokie.
NorthShore University HealthSystem offers both medicinal care as well as classes assisting with living health. Their available services include assistance with cancer, neurological, cardiovascular, and orthopedics care. Classes offered include cardiac care, childbirth, CPR/First Aid, diabetes, and many others.
NuMat Technologies is a materials technology company committed to enabling fundamental performance shifts in the gas storage and separations industries. We will do so by tailor-designing nanoporous materials, specifically Metal Organic Frameworks ("MOFs"), for high-value applications which critically depend on material performance.
Oakton Community College is a comprehensive 2 year school that serves District 535 of the Illinois Community College system. This is essentially the north suburban region of Cook County. The College offers courses for university transfer, career entry and enhancement as well as developmental curriculum.
The nanotechnology laboratory courses represent an effort at career training in the area that we plan to share with district high schools by negotiating various dual credit agreements. With appropriate funding, we intend to also offer industrial seminars on the topic. Click for Oakton Community College
Polyera BREAKTHROUGH TECHNOLOGY
Made possible by breakthrough Polyera materials, our technology enables truly flexible transistors to be made using advanced manufacturing techniques. This technology enables more than just putting traditional transistors on flexible materials like plastic – it allows us to make transistors that are themselves flexible: a whole different level of technology. Our materials can also be made into functional inks, allowing not only traditional photolithography-based electronics manufacturing, but new low-cost, high-throughput forms of manufacturing such as printing.
A community of entrepreneurs bringing innovation to market. The Technology Innovation Center (TIC) is a business incubator dedicated to supporting the growth of very early stage technology-based businesses. It is an extremely entrepreneurial business environment that fosters collaboration and sharing among young companies, while respecting the independence and self-reliance that motivates entrepreneurs. It is a community with a culture that supports risk taking, invention and the creation of wealth.
Unity Lab Services complements our Thermo Scientific and Fisher Scientific brands. Unity Lab Services was created by listening to the voice of our customers. It represents our ability to leverage our entire portfolio of laboratory support services to provide integrated solutions through a single point of contact, so our customers can focus on their important work. Our customized service offerings and world-class service experts have the flexibility and experience to uniquely address your business needs. Whether you are looking to arrange for service on one instrument, or are seeking resources to manage service and support for all your labs, there is a Unity Lab Services solution for your lab.
Unity Lab Services Provides:
- Simple Access to Integrated Service Delivery: Unity Lab Services provides complete solution design and implementation for seamless laboratory service and support management with one partner.
- One Solution, Regardless of Vendor: Service and support programs for all instruments and supplies, regardless of manufacturer.
- Proven Expertise, Tangible Results: Our SmartSystem program model leverages more than 50 years of service experience and features our proprietary Smart Trac metrics so you can closely monitor your program results
UQSI is a US based international team of Pharmaceutical Consultants providing a wide range of consulting services to Pharmaceutical, Biotechnology and Active Pharmaceutical Ingredients (APIs) Industry.
Our team of professionals can provide operational assistance in Quality functions, Commissioning & Qualification, Validation, cGMP Compliance, Regulatory Affairs, design and construction supervision for new plants. Our team is well experienced to meet your immediate and long term requirements of skilled biotech and pharma science trained, experienced staff.
Vetter is an international contract development and manufacturing organization specializing in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with a broad array of substances, including monoclonal antibodies, peptides, interferons and vaccines. An independent firm headquartered in Ravensburg, Germany, Vetter provides support for pharmaceutical and biotech clientsfrom preclinical development through regulatory approval and global market supply. Vetter’s new Chicago facility, an expansion of Vetter Development Service, supports early-stage products.
The firm works with the world’s leading pharmaceutical and biotech companies, and employs approximately 3,600 staff across Europe and the United States. The innovator of the Vetter Lyo-Ject® dual-chamber syringe and V-LK® cartridge, the company holds numerous patents and is a leader in the use of RABS technology in cleanrooms. Approved as a foreign manufacturer by the government of Japan, Vetter’s global regulatory experience includes numerous customer product approvals by the FDA, EMA and other authorities. Over its more than 35-year history in aseptic filling, Vetter has won many awards for its facilities and operations, including Frost & Sullivan’s 2011 European Prefilled Injection Systems Customer Service Leadership Award.